Lack of Disclosure on Unregistered Equity Sales Clouds Dilution Risks at Kiniksa PharmaceuticalsTip Ranks·8 hours agoKNSA-0.89%
Wedbush Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) StockMarket Beat·21 hours agoKNSA-0.89%UBS+2.20%
Top Biotech Gainers: KNSA Soars On Q2 Results, TRIB, OPK On Watch, MPLT On The Mend?rttnews·1 day ago, 09:50 PMTRIB+0.87%KNSA-0.89%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·1 day ago, 12:06 PMREPL0.00%BMY+1.31%
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesdaybenzinga_article·2 days ago, 09:05 AMAWI-2.02%KO-1.91%
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Posts Quarterly Earnings Results, Hits EstimatesMarket Beat·2 days ago, 06:56 AMKNSA-0.89%
Kiniksa Pharmaceuticals | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 243.6 MEarnings Watch·2 days ago, 06:35 AMKNSA-0.89%
Kiniksa Pharmaceuticals to report Q2 2026 results in conference call and webcastPUBT·Jul 23 at 03:03 PMKNSA-0.89%
